PD-1/CTLA-4

Clinical trials for PD-1/CTLA-4 explained in plain language.

Never miss a new study

Get alerted when new PD-1/CTLA-4 trials appear

Sign up with your email to follow new studies for PD-1/CTLA-4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare stomach cancer: Four-Drug combo targets tumors after first treatment fails

Disease control Recruiting now

This study tests a combination of four drugs (iparomlimab, tuvonralimab, apatinib, and irinotecan) in 39 adults with advanced AFP-producing stomach or gastroesophageal junction cancer that worsened after initial PD-1 inhibitor plus chemotherapy. The goal is to see if this new mix…

Matched conditions: PD-1/CTLA-4

Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control

Last updated May 22, 2026 14:04 UTC

PD-1/CTLA-4

Get alerted when new PD-1/CTLA-4 trials appear

New hope for rare stomach cancer: Four-Drug combo targets tumors after first treatment fails